Excitation by dopamine of rat subthalamic nucleus neurones in vitro - A direct action with unconventional pharmacology

Neuroscience

Volumn 116, Issue 1, 2003, Pages 157-166

  Tofighy, A ^a   Abbott, A ^a   Centonze, D ^a   Cooper, A J ^a   Noor, E ^a   Pearce, S M ^a   Puntis, M ^a   Stanford, I M ^a   Wigmore, M A ^a   Lacey, M G ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Adrenoceptors; Basal ganglia; Brain slices; Dopamine receptors; Single unit recording; Whole cell patch clamp

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; AMPHETAMINE; BROMOCRIPTINE; BUTACLAMOL; CATECHOLAMINE; DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; ETICLOPRIDE; PHENTOLAMINE; PICROTOXIN; PRAZOCIN; PROPRANOLOL; QUINPIROLE; SULPIRIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CATECHOLAMINE RELEASE; CONTROLLED STUDY; CYTOPLASM; DEPOLARIZATION; DIALYSIS; ELECTRIC RESISTANCE; ELECTROPHYSIOLOGY; IN VITRO STUDY; MALE; NERVE CELL; NERVE CELL MEMBRANE POTENTIAL; NERVE EXCITABILITY; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; RECORDING; SINGLE UNIT ACTIVITY; SUBTHALAMIC NUCLEUS; SYNAPTIC TRANSMISSION;

AMPHETAMINE; ANIMALS; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; MALE; NEURONS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE; SUBTHALAMIC NUCLEUS;

EID: 0037439188     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00546-8     Document Type: Article

References (64)

1. Abbott A., Wigmore M.A., Lacey M.G. Excitation of rat subthalamic nucleus neurones in vitro by activation of a group I metabotropic glutamate receptor. Brain Res. 766:1997;162-167.
2. Augood S.J., Hollingsworth Z.R., Standaert D.G., Emson P.C., Penney J.B. Jr. Localization of dopaminergic markers in the human subthalamic nucleus. J Comp Neurol. 421:2000;247-255.
3. 2 receptor subtypes A family re-united. Trends Pharmacol Sci. 16:1995;105-110.
4. Bergman H., Wichmann T., Delong M.R. Reversal of experimental Parkinsonism by lesions of the subthalamic nucleus. Science. 249:1990;1436-1438.
5. Bergman H., Wichmann T., Karmon B., Delong M.R. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol. 72:1994;507-520.
6. Beurrier C., Congar P., Bioulac B., Hammond C. Subthalamic nucleus neurons switch from single-spike activity to burst-firing mode. J Neurosci. 19:2000;599-609.
7. Bevan M.D., Wilson C.J. Mechanisms underlying spontaneous oscillation and rhythmic firing in rat subthalamic neurons. J Neurosci. 19:1999;7617-7628.
8. 125I]iodosulpiride. Neuroscience. 20:1987;117-155.
9. 2 receptor mRNA. Brain Res. 564:1991;203-219.
10. Brown L.L., Makman M.H., Wolfson L.I., Dvorkin B., Warner C., Katzman R. A direct role of dopamine in the rat subthalamic nucleus and an adjacent intrapeduncular area. Science. 206:1979;1416-1418.
11. Bunzow J.R., Sonders M.S., Arttamangkul S., Harrison L.M., Zhang G., Quigley D.I., Darland T., Suchland K.L., Pasumamula S., KENNEDY J.L., Olson S.B., Magenis R., Amara S.G., Grandy D.K. Amphetamine, 3, 4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Molecular Pharmacology. 60:2001;1181-1188.
12. Bylund D.B., Eikenberg D.C., Hieble J.P., Langer S.Z., Lefkowitz R.J., Minneman K., Molinoff P.B., Ruffolo R.R., J.r, Trendelenburg U. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev. 46:1994;121-136.
13. Campbell G.A., Eckardt M.J., Weight F.F. Dopaminergic mechanisms in the subthalamic nucleus of rat Analysis using horseradish peroxidase and microiontophoresis. Brain Res. 333:1985;261-270.
14. Crespi D., Mennini T., Gobbi M. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3, 4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine. Br J Pharmacol. 121:1997;1735-1743.
15. Dawson T.M., Gehlert D.R., McCabe R.T., Barnett A., Walmsley J.K. D-1 dopamine receptors in the rat brain A quantitative autoradiographic analysis. J Neurosci. 6:1986;2352-2365.
16. Flores G., Liang J.J., Sierra A., Martínez-Fong D., Quirion R., Aceves J., Srivastava L.K. Expression of dopamine receptors in the subthalamic nucleus of the rat Characterization using reverse transcriptase polymerase chain reaction and autoradiography. Neuroscience. 91:1999;549-556.
17. Flores G., Rosales M.G., Hernández S., Sierra A., Aceves J. 5-hydroxytryptamine increases spontaneous activity of subthalamic neurons in the rat. Neurosci Lett. 192:1995;17-20.
18. Flores G., Valencia J., Rosales M.G., Sierra A., Aceves J. Appearance of EMG activity and motor asymmetry after unilateral lesions of the dopaminergic inervation to the subthalamic nucleus in the rat. Neurosci Lett. 162:1993;153-156.
19. François C., Savy C., Jan C., Tande D., Hirsch E.C., Yelnik J. Dopaminergic innervation of the subthalamic nucleus in the normal state, in MPTP-treated monkeys, and in Parkinson's disease patients. J Comp Neurol. 425:2000;121-129.
20. Fremeau R.T., Duncan G.E., Fornaretto M.G., Dearry A., Gingrich J.A., Breese G.R., Caron M.G. Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. Proc Natl Acad Sci USA. 88:1991;3772-3776.
21. 1 receptors form functionally interacting heteromeric complexes. Proc Natl Acad Sci USA. 97:2000;8606-8611.
22. Gingrich J.A., Caron M.G. Recent advances in the molecular biology of dopamine receptors. Annu Rev Neurosci. 16:1993;299-321.
23. Hassani O.K., Féger J. Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats An electrophysiological and c-Fos study. Neuroscience. 92:1999;533-543.
24. Hassani O.K., François C., Yelnik J., Féger J. Evidence for a dopaminergic innervation of the subthalamic nucleus in the rat. Brain Res. 749:1997;88-94.
25. Hassani O.K., Mouroux M., Féger J. Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus. Neuroscience. 72:1996;105-115.
26. 1 receptors elicits akinesia in rats. Neuroreport. 9:1998;4115-4118.
27. Hedreen J.C. Tyrosine hydroxylase-immunoreactive elements in the human globus pallidus and subthalamic nucleus. J Comp Neurol. 409:1999;400-410.
28. Johnson A.E., Coirini H., Källström L., Wiesel F.-A. Characterization of dopamine receptor binding sites in the subthalamic nucleus. Neuroreport. 5:1994;1836-1838.
29. Kreiss D.S., Anderson L.A., Walters J.R. Apomorphine and dopamine D1 receptor agonists increase the firing rates of subthalamic nucleus neurons. Neuroscience. 72:1996;863-876.
30. Lacey M.G., Mercuri N.B., North R.A. Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. J Physiol (Lond.). 392:1987;397-416.
31. Lacey M.G., Mercuri N.B., North R.A. Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actions of dopamine and opioids. J Neurosci. 9:1989;1233-1241.
32. Limousin P., Krack P., Pollak P., Benazzouz A., Ardouin C., Hoffmann D., Benabid A.L. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med. 339:1998;1105-1111.
33. 1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques. Neuroscience. 46:1992;959-971.
34. Matsumoto M., Hidaka K., Tada S., Tasaki Y., Yamaguchi T. Low levels of mRNA for dopamine D4 receptor in human cerebral cortex and striatum. J Neurochem. 66:1996;915-919.
35. Mehta A., Thermos K., Chesselet M.F. Increased behavioral response to dopaminergic stimulation of the subthalamic nucleus after nigrostriatal lesions. Synapse. 37:2000;298-307.
36. Meibach R.C., Katzman R. Catecholaminergic innervation of the subthalamic nucleus Evidence for a rostral continuation of the A9 (substantia nigra) dopaminergic cell group. Brain Res. 173:1979;364-368.
37. Mintz I., Hammond C., Feger J. Excitatory effect of iontophoretically applied dopamine on identified neurons of the rat subthalamic nucleus. Brain Res. 375:1986;172-175.
38. Missale C., Nash S.R., Robinson S.W., Jaber M., Caron M.G. Dopamine receptors From structure to function. Physiol Rev. 78:1998;189-225.
39. 125I]sulpiride binding in the subthalamic nucleus of rats with nigrostriatal lesions. Neuroreport. 10:1999;1501-1505.
40. Ni Z., Bouali-Benazzouz R., Gao D., Benabid A.L., Benazzouz A. Intrasubthalamic injection of 6-hydroxydopamine induces changes in the firing rate and pattern of subthalamic nucleus neurons in the rat. Synapse. 40:2001;145-153.
41. Ni Z., Gao D., Bouali-Benazzouz R., Benabid A.L., Benazzouz A. Effect of microiontophoretic application of dopamine on subthalamic nucleus neuronal activity in normal rats and in rats with unilateral lesion of the nigrostriatal pathway. Eur J Neurosci. 14:2001;373-381.
42. Obeso J.A., Rodríguez-Oroz M.C., Rodríguez M., Lanciego J.L., Artieda J., Gonzalo N., Olanow C.W. Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci. 23:2000;S8-S19.
43. Overton P.G., O'Callaghan J.F.X., Greenfield S.A. Possible intermixing of neurons from the subthalamic nucleus and substantia nigra pars compacta in the guinea-pig. Exp Brain Res. 107:1995;151-165.
44. Parry T.J., Eberle-Wang K., Lucki I., Chesselet M.F. Dopaminergic stimulation of subthalamic nucleus elicits oral dyskinesia in rats. Exp Neurol. 128:1994;181-190.
45. Patel S., Freedman S., Chapman K.L., Emms F., Fletcher A.E., Knowles M., Marwood R., McAllister G., Myers J., Curtis N., Kulagowski J.J., Leeson P.D., Ridgill M., Graham M., Matheson S., Rathbone D., Watt A.P., Bristow L.J., Rupniak N.M.J., Baskin E., Lynch J.J., Ragan C.I. Biological profile of L-745, 870, a selective antagonist with high affinity for the dopamine D4 receptor. J Pharmacol Exp Ther. 283:1997;636-647.
46. Pinnock R.D. The actions of antipsychotic drugs on dopamine receptors in the rat substantia nigra. Br J Pharmacol. 81:1984;631-635.
47. Prensa L., Cossette M., Parent A. Dopaminergic innervation of human basal ganglia. J Chem Neuroanat. 20:2000;207-213.
48. Prensa L., Parent A. The nigrostriatal pathway in the rat A single-axon study of the relationship between dorsal and ventral tier nigral neurons and the striosome/matrix striatal compartments. J Neurosci. 21:2001;7247-7260.
49. Rocheville M., Lange D.C., Kumar U., Patel S.C., Patel R.C., Patel Y.C. Receptors for dopamine and somatostatin Formation of hetero-oligomers with enhanced functional activity. Science. 288:2000;154-157.
50. Rothman R.B., Baumann M.H., Dersch C.M., Romero D.V., Rice K.C., Carroll F.I., Partilla J.S. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse. 39:2001;32-41.
51. Ruffolo R.R. Jr, Nichols A.J., Stadel J.M., Hieble J.P. Structure and function of alpha-adrenoceptors. Pharmacol Rev. 43:1991;475-505.
52. Scarselli M., Novi F., Schallmach E., et al. D2/D3 dopamine receptor heterodimers exhibit unique functional properties. J Biol Chem. 276:2001;30308-30314.
53. Schwartz J.-C., Giros B., Martres M.-P., Sokoloff P. The dopamine receptor family Molecular biology and pharmacology. Semin Neurosci. 4:1992;99-108.
54. Seiden L.S., Sabol K.E., Ricaurte G.A. Amphetamine Effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol. 33:1993;639-677.
55. 3 receptors inhibit excitatory and inhibitory transmission to rat subthalamic neurones in vitro. J of Physiology. 525:2000;331-341.
56. Smith Y., Bevan M.D., Shink E., Bolam J.P. Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience. 86:1998;353-387.
57. Smith Y., Kieval J.Z. Anatomy of the dopamine system in the basal ganglia. Trends Neurosci. 23:2000;S28-S33.
58. Smith Y., Parent A. Neurons of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivity. Brain Res. 453:1988;353-356.
59. Tofighy A., Lacey M.G. Atypical pharmacology of the excitation by dopamine of rat subthalamic nucleus neurones in vitro. Br J Pharmacol. 126:1999;9P.
60. Vallone D., Picetti R., Borrelli E. Structure and function of dopamine receptors. Neurosci Biobehav Rev. 24:2000;125-132.
61. + current in rat subthalamic nucleus neurones. J Physiol. 527:2000;493-506.
62. Woodward R.M., Panicker M.M., Miledi R. Actions of dopamine and dopaminergic drugs on cloned serotonin receptors expressed in Xenopus oocytes. Proc Natl Acad Sci USA. 89:1992;4708-4712.
63. Zhu Z.-T., Shen K.-Z., Johnson S.W. Pharmacological identification of inward current evoked by dopamine in rat subthalamic neurons in vitro. Neuropharmacology. 42:2000;772-781.
64. Zhu Z.-T., Bartol M., Shen K.-Z., Johnson S.W. Excitatory effects of dopamine on subthalamic nucleus neurons: in vitro study of rats pretreated with 6-hydroxydopamine and levodopa. Brain Res. 945:2000;31-40.